Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.21
-0.13-1.71%
Last update: Dec 16, 10:52 AM
Comments
Loading...
Bicycle Therapeutics (BCYC) Stock Price, Quote, News & History
BCYCNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bicycle Therapeutics (BCYC) stock?
You can purchase shares of Bicycle Therapeutics (NASDAQ:BCYC) through any online brokerage.
Who are Bicycle Therapeutics (BCYC) competitors?
Other companies in Bicycle Therapeutics’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), Galectin Therapeutics Inc (NASDAQ:GALT), Monopar Therapeutics Inc (NASDAQ:MNPR), Altimmune Inc (NASDAQ:ALT) and ADC Therapeutics SA (NYSE:ADCT).
What is the forecast, or price target, for Bicycle Therapeutics (BCYC) stock?
Bicycle Therapeutics has a consensus price target of $24.75.
What is the current price for Bicycle Therapeutics (BCYC)?
The stock price for Bicycle Therapeutics (NASDAQ: BCYC) is $7.205 last updated December 16, 2025 at 10:52 AM EST.
Does Bicycle Therapeutics (BCYC) pay a dividend?
There are no upcoming dividends for Bicycle Therapeutics.
When is Bicycle Therapeutics (NASDAQ:BCYC) reporting earnings?
Bicycle Therapeutics does not have any upcoming earnings scheduled.
Is Bicycle Therapeutics (BCYC) going to split?
There is no upcoming split for Bicycle Therapeutics.
What sector and industry does Bicycle Therapeutics (BCYC) operate in?
Bicycle Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
